Article
SGLT2 inhibition, high-density lipoprotein cholesterol and aortic aneurysm: A drug-target Mendelian randomization study.
Nutrition, metabolism, and cardiovascular diseases : NMCD - 1 Aug 2026
Song Zheng-Qi, Pei Yan-Zhen, Wu Sheng-Ke, Chen Xiu-Xiu, Chen Yi-He
Abstract excerpt
BACKGROUND AND AIM: The causal effect of sodium-glucose cotransporter 2 (SGLT2) inhibition on aortic aneurysm (AA), as well as the underlying lipid metabolism, remain largely unexplored. METHODS AND RESULTS: We extracted genetic variants within the cis-region of the SLC5A2 gene from the genome-wide association study of hemoglobin A1c (HbA1c) to proxy the effects of SGLT2 inhibition. Two-sample Mendelian...
Topics
- Humans
- Mendelian Randomization Analysis
- Diabetes Mellitus, Type 2
- Sodium-Glucose Transporter 2 Inhibitors
- Biomarkers
- Sodium-Glucose Transporter 2
- Risk Factors
- Cholesterol, HDL
- Risk Assessment
- Genome-Wide Association Study
